Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Comparison of the measurement properties of the EQ-5D-5L and SF-6Dv2 among patients with diabetes in China.

PMID: 41437075 · 2025

JournalHealth and quality of life outcomes
Year2025
PMID41437075

Abstract

To validate and compare the measurement properties of the EQ-5D-5L and SF-6Dv2 among patients with diabetes in China. A quota sampling method was used to recruit a representative sample, social-demographic characteristics, self-reported EQ-5D-5L and SF-6Dv2 responses were collected through online survey. Test-retest reliability and the agreement between EQ-5D-5L and SF-6Dv2 utility values were assessed using the intraclass correlation coefficient (ICC) and the Bland-Altman plot. Hypotheses testi

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.